John Peter Gutfreund - Former Director at Oncocyte Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Former Director
Stock Symbol
OCX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Peter Gutfreund since 4/23/2024

Holdings reported by John Peter Gutfreund for Oncocyte Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, no par value 715K $154K $0.21 Jun 30, 2023 Direct
Option to Purchase Common Stock 45K Aug 15, 2022 Direct Common Stock
Warrants to Purchase Common Stock 45K Jun 30, 2023 Direct Common Stock 45K
Common Stock, no par value 0 $0.21 Jun 30, 2023 Indirect
Series A Convertible Preferred Stock 0 Apr 3, 2023 Direct Common Stock, no par value
Warrants to Purchase Common Stock 0 Jun 30, 2023 Indirect Common Stock

Transactions reported by John Peter Gutfreund for Oncocyte Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.